Serving hundreds of leading biopharmaceutical companies globally:

Generated: November 17, 2018

DrugPatentWatch Database Preview

Pembrolizumab - Biologic Drug Details

« Back to Dashboard

Summary for pembrolizumab

Tradenames:	1
Patents:	26
Applicants:	1
BLAs:	1
Suppliers: see list	1

Pharmacology for pembrolizumab

Mechanism of Action	Programmed Death Receptor-1-directed Antibody Interactions

US Patents for pembrolizumab

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Merck Sharp Dohme	KEYTRUDA	pembrolizumab	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER	125514	001	2014-09-04	➤ Try a Free Trial	Celgene Corporation (Summit, NJ) The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, DC)	➤ Try a Free Trial	RX	Orphan	search
Merck Sharp Dohme	KEYTRUDA	pembrolizumab	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER	125514	001	2014-09-04	➤ Try a Free Trial		➤ Try a Free Trial	RX	Orphan	search
Merck Sharp Dohme	KEYTRUDA	pembrolizumab	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER	125514	001	2014-09-04	➤ Try a Free Trial	KANGPU BIOPHARMACEUTICALS, LTD. (Shanghai, CN)	➤ Try a Free Trial	RX	Orphan	search
Merck Sharp Dohme	KEYTRUDA	pembrolizumab	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER	125514	001	2014-09-04	➤ Try a Free Trial	MedImmune Limited (Cambridge, GB)	➤ Try a Free Trial	RX	Orphan	search
Merck Sharp Dohme	KEYTRUDA	pembrolizumab	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER	125514	001	2014-09-04	➤ Try a Free Trial	Advenchen Pharmaceuticals, LLC (Moorpark, CA)	➤ Try a Free Trial	RX	Orphan	search
Merck Sharp Dohme	KEYTRUDA	pembrolizumab	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER	125514	001	2014-09-04	➤ Try a Free Trial	Yeda Research and Development Co. Ltd (Rehovot, IL)	➤ Try a Free Trial	RX	Orphan	search
Merck Sharp Dohme	KEYTRUDA	pembrolizumab	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER	125514	001	2014-09-04	➤ Try a Free Trial	Flexus Biosciences, Inc. (Princeton, NJ)	➤ Try a Free Trial	RX	Orphan	search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

International Patents for pembrolizumab

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
Eurasian Patent Organization	201691872	➤ Try a Free Trial
Russian Federation	2015103345	➤ Try a Free Trial
World Intellectual Property Organization (WIPO)	2014028560	➤ Try a Free Trial
European Patent Office	3169355	➤ Try a Free Trial
Australia	2015231413	➤ Try a Free Trial
Japan	2017507936	➤ Try a Free Trial
Hungary	E032459	➤ Try a Free Trial
Country	Document Number	Estimated Expiration

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb

Johnson and Johnson

McKesson

Moodys

Boehringer Ingelheim

Farmers Insurance

McKinsey

Daiichi Sankyo

Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.